Ó£»¨ÊÓƵ

Skip to main content

Table 6 Changes in out-of-clinic time use by domains (MARCA; min/day) in the standard clinic (C) and the text message-enhanced clinic (EC)

From: Feasibility, acceptability and efficacy of a text message-enhanced clinical exercise rehabilitation intervention for increasing ‘whole-of-day’ activity in people living with and beyond cancer

ÌýÌý

Week 4 (clinic cessation)

Week 12 (text cessation)

Week 12-Week 4

n

M (95%CI)

P

n

M (95%CI)

P

M (95%CI)

p

Chores (min/day)

C

17

−19.2 (−51.9, 13.5)

0.249

15

−26.3 (−64.5, 11.9)

0.177

−7.1 (−47.7, 33.6)

0.734

EC

18

−21.5 (−53.0, 10.1)

0.182

15

−11.1 (−49.2, 27.0)

0.568

10.4 (−29.9, 50.7)

0.614

EC-C

Ìý

−2.2 (−50.1, 45.7)

0.928

Ìý

15.2 (−41.0, 71.4)

0.5962

17.4 (−39.8, 74.6)

0.550

Cultural

C

17

−2.0 (−11.6, 7.6)

0.682

15

−4.7 (−6.6, − 2.9)

&±ô³Ù; 0.001

− 2.7 (− 13.2, 7.8)

0.612

EC

18

−0.2 (−9.5, 9.1)

0.964

15

−4.7 (−6.6, − 2.9)

&±ô³Ù; 0.001

− 4.5 (− 14.7, 5.6)

0.382

EC-C

Ìý

1.8 (−11.6, 15.2)

0.794

Ìý

0.0 (−2.8, 2.7)

0.978

−1.8 (− 16.4, 12.8)

0.806

Physical Activity

C

17

8.1 (−0.1, 16.4)

0.054

15

17.1 (2.7, 31.5)

0.020

9.0 (−1.9, 19.9)

0.107

EC

18

9.1 (1.1, 17.1)

0.026

15

14.8 (0.6, 29.0)

0.041

5.8 (−5.2, 16.7)

0.301

EC-C

Ìý

0.9 (−11.3, 13.1)

0.881

Ìý

−2.3 (−22.9, 18.3)

0.828

−3.2 (−18.6, 12.2)

0.682

Quiet time

C

17

7.2 (−17.8, 32.3)

0.571

15

28.0 (−4.5, 60.4)

0.091

20.7 (−15.1, 56.5)

0.256

EC

18

−14.7 (−38.9, 9.5)

0.233

15

−35.3 (−67.7, −2.9)

0.033

−20.6 (−56.1, 14.9)

0.256

EC-C

Ìý

−21.9 (−58.4, 14.6)

0.239

Ìý

−63.3 (−110.5, − 16.0)

0.009

−41.3 (−91.8, 9.1)

0.108

Screen time

C

17

15.1 (−32.0, 62.1)

0.530

15

1.4 (−56.7, 59.5)

0.962

−13.7 (−61.5, 34.2)

0.576

EC

18

13.3 (−32.0, 58.7)

0.564

15

−48.6 (−106, 8.8)

0.097

−1.7 (−70.8, 67.3)

0.960

EC-C

Ìý

−50.0 (− 134.8, 34.7)

0.247

Ìý

−62.0 (− 109.7, − 14.2)

0.011

− 48.3 (− 115.9, 19.3)

0.161

Self-care

C

17

−1.9 (− 18.3, 14.4)

0.818

15

3.8 (−12.1, 19.7)

0.638

5.7 (−12.6, 24.1)

0.541

EC

18

1.7 (−14.2, 17.5)

0.836

15

0.5 (−15.3, 16.4)

0.949

−1.1 (− 19.3, 17.0)

0.901

EC-C

Ìý

3.6 (−20.2, 27.4)

0.768

Ìý

−3.3 (− 26.9, 20.3)

0.784

−6.9 (− 32.7, 18.9)

0.601

Social

C

17

−41.0 (−67.9, −14.1)

0.003

15

−22.3 (−62.2, 17.6)

0.274

18.7 (−18.6, 56.0)

0.326

EC

18

−22.5 (−47.9, 2.8)

0.081

15

0.2 (−39.5, 39.8)

0.994

18.4 (−22.0, 58.8)

0.371

EC-C

Ìý

22.4 (−36.5, 81.3)

0.455

Ìý

22.7 (−14.5, 59.9)

0.232

4.0 (−48.7, 56.7)

0.881

Transport

C

17

4.5 (−23.0, 32.1)

0.747

15

1.2 (−24.4, 26.7)

0.929

−3.4 (−37.9, 31.1)

0.848

EC

18

−6.4 (−33.1, 20.2)

0.636

15

11.8 (−13.8, 37.4)

0.368

18.2 (−15.8, 52.2)

0.294

EC-C

Ìý

−11 (−50.6, 28.6)

0.587

Ìý

10.6 (−27.0, 48.2)

0.581

21.6 (−26.9, 70.0)

0.383

Work & Study

C

17

−4.9 (−33.3, 23.6)

0.738

15

−3.0 (− 32.8, 26.8)

0.846

1.9 (−23.5, 27.3)

0.883

EC

18

26.9 (−0.7, 54.5)

0.056

15

27.1 (−2.4, 56.5)

0.072

0.2 (−25.1, 25.4)

0.991

EC-C

Ìý

31.8 (−12.3, 75.8)

0.158

Ìý

30.0 (− 16.1, 76.1)

0.202

− 1.7 (−37.5, 34.0)

0.924

  1. Table presents mean change over time or mean difference between groups (M) with 95% Confidence Interval (CI) as estimated by mixed models adjusting for baseline values of the outcome, age (years), gender (male/female), time since diagnosis (months) and number of medications currently taken (0/1/≥2). Bold text indicates changes that were significant at p < 0.05
Back to article page

Ó£»¨ÊÓƵ

ISSN: 1471-2458

Contact us